A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study) — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(6 sites)
United States
UC San Diego, La Jolla, California Rush University Medical Center, Chicago, Illinois Boston Children's Hospital, Boston, Massachusetts Washington University, St. Louis, St Louis, Missouri UT Southwestern Children's Medical Center, Dallas, Texas Canada
CHU St. Justine, Montreal, Quebec Last updated December 2025